Increasingly potent immunosuppressive agents have dramatically reduced the incidence of rejection of transplanted organs while increasing susceptibility to opportunistic infections and cancer. This article reviews general concepts for the management of transplantation-associated infections and discusses recent advances and challenges.
No takes yet. Share an insight, caveat, or question.
Jay A. Fishman (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: